Press release
Diabetic Retinopathy Market Global Industry Trends, Growth, Share, Size and Forecast Research Report 2032
The global diabetic retinopathy market is expected to witness substantial growth in the coming years, fueled by the rising prevalence of diabetes and the increasing need for early diagnosis and treatment. According to a report by Reports and Data, the market size was valued at USD 7.0 Billion in 2022 and is projected to reach USD 11.83 Billion by 2032, registering a compound annual growth rate (CAGR) of 6% from 2022 to 2032.Market Overview
Diabetic retinopathy (DR) is a microvascular complication of diabetes that damages the blood vessels in the retina, the light-sensitive layer of the eye. Early detection and management are crucial to prevent vision loss and blindness. The diabetic retinopathy market encompasses various diagnostic tools, therapeutic interventions, and technologies used for screening, diagnosis, and treatment of DR.
Claim Your FREE Sample Copy with Table of content@ https://www.reportsanddata.com/download-free-sample/1484
Key Trends Shaping the Market
Technological Advancements: The emergence of advanced diagnostic tools like artificial intelligence (AI)-powered image analysis systems and teleophthalmology for remote screening is driving market growth.
Growing Geriatric Population: The aging population is at a higher risk of developing diabetes and its complications, including DR, increasing the patient pool.
Rising Healthcare Awareness: Growing public awareness about diabetes and the importance of regular eye examinations is propelling the demand for DR screening and treatment services.
Focus on Early Detection: Early diagnosis and intervention are crucial for preventing vision loss. This trend is fueling the adoption of advanced diagnostic tools and diabetic retinopathy screening programs.
Market Drivers and Restraints
Drivers:
Increasing prevalence of diabetes
Growing geriatric population
Technological advancements in diagnosis and treatment
Rising healthcare awareness
Restraints:
High cost of advanced DR treatment technologies
Limited access to healthcare facilities in developing regions
Lack of skilled healthcare professionals
Growth Opportunities
Development of cost-effective diagnostic tools and treatment modalities
Increasing government initiatives for diabetic retinopathy screening programs
Expansion of teleophthalmology services in remote areas
Growing focus on personalized medicine for DR treatment
For more informative information, please visit us @ https://www.reportsanddata.com/report-detail/diabetic-retinopathy-market
Market Insights
North America currently dominates the diabetic retinopathy market due to the high prevalence of diabetes, well-developed healthcare infrastructure, and early adoption of advanced technologies.
The Asia Pacific region is expected to witness the fastest growth rate in the coming years due to the rising diabetic population and increasing government healthcare investments.
Key players in the market are focusing on strategic collaborations, mergers and acquisitions, and new product development to expand their market share.
SWOT Analysis
Strengths:
Growing demand for DR diagnosis and treatment
Technological advancements in the field
Increasing awareness about diabetic retinopathy
Weaknesses:
High cost of treatment
Limited access to healthcare in developing regions
Shortage of skilled healthcare professionals
Opportunities:
Development of cost-effective technologies
Expansion of teleophthalmology services
Growing focus on preventive healthcare
Threats:
Stringent government regulations
Reimbursement challenges
Latest Strategic Developments
Novartis International AG: In 2021, Novartis launched a new drug called Beovu® (brolucizumab) for the treatment of diabetic macular edema. Beovu® is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), a protein that contributes to the development of diabetic retinopathy.
Regeneron Pharmaceuticals Inc.: In 2019, Regeneron Pharmaceuticals launched a new drug called EYLEA® (aflibercept) Injection to treat diabetic retinopathy. EYLEA® is administered by injection into the eye and has been shown to improve vision in patients with diabetic retinopathy.
Competitive Landscape:
The global diabetic retinopathy market is highly competitive and fragmented, with a number of large and medium-sized players accounting for a majority of market revenue. Major players are deploying various strategies, including entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective products. Some major companies included in the global diabetic retinopathy market report are:
Novartis International AG
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals Inc.
Bayer AG
Allergan plc
Genentech, Inc.
Alimera Sciences, Inc.
Adverum Biotechnologies, Inc.
Aerpio Pharmaceuticals, Inc.
Iveric bio, Inc.
Segments Covered in the Report:
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of market trends in each of segments and sub-segments from 2019 to 2032. For the purpose of this report, Reports and Data has segmented the global diabetic retinopathy market based on type, end-use, and region:
By Type Outlook
Proliferative
Non-Proliferative
By End-use Outlook
Hospitals
Clinics
Ambulatory Surgical Centers
Ask For Customization: https://www.reportsanddata.com/request-customization-form/1484
Country scope:
U.S.; Canada; U.K.; Germany; France; BENELUX; China; India; Japan; South Korea; Brazil; Saudi Arabia; UAE; Turkey
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Retinopathy Market Global Industry Trends, Growth, Share, Size and Forecast Research Report 2032 here
News-ID: 3558151 • Views: …
More Releases from Reports And Data

Forensic Technology Market Size ,Growth Research Report 2024-2032 | 250 Pages
The global forensic technology market is forecast to reach a market size of USD 50.41 Billion by 2027 and register a rapid revenue growth rate over the next seven years, according to a new report by Reports and Data. The forensic technology market continues to register major growth owing to increasing demand and usage of advanced technologies to solve crimes. High demand for these solutions is also due to upsurge…

Folinic Acid Market Size ,Growth Research Report 2024-2026 | 250 Pages
The global Folinic acid industry is projected to undergo a steady growth in the forecasted years as observed by the outcome of the analysis provided in this study. The report encompasses the different factors that have a substantial impact on revenue of the businesses. This study also profiles the key players that account for a significant share in the global economy of the Folinic acid business. The key players have…

Crizotinib Market Size ,Growth Research Report 2024-2026 | 250 Pages
This Crizotinib market research provides a comprehensive study of the industry's size, share, demand, growth, gross profits, earnings, and sales. It analyzes the data acquired to provide a comprehensive perspective of industry trends and forecasts probable developments throughout the anticipated time period. For this study, historical data from 2016 and 2017 was collected, with 2018 serving as the base year to forecast the industry's growth from 2019 to 2026.
The global…

Palbociclib Market Size ,Growth Research Report 2024-2026 | 250 Pages
The global Palbociclib industry is expected to grow steadily in the upcoming years. Asia Pacific is anticipated to expand at the fastest CAGR of 12% during the forecast period. The other geographical regions covered in this study are Europe, North America, Latin America, Middle East and Africa. The key players in the Palbociclib drug businesses are Pfizer, Beacon Pharmaceuticals, Incepta Pharmaceuticals, Bluepharma, NANO DARU, among others. The data here offers…
More Releases for Growing
Smart Pneumatics Market Global Growing Trends by 2028 - Growing Awareness toward …
Smart Pneumatics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Component (Hardware, Software, Services); Type (Smart Pneumatic Valves, Smart Pneumatic Actuators, Smart Pneumatic Modules); Industry (Oil and Gas, Energy and Power, Water and Wastewater, Automotive, Semiconductor, Food and Beverages, Chemicals, Pharmaceuticals) and Geography
Smart pneumatics is heavily influenced by driving factors such as growing awareness toward predictive maintenance, penetration of digitization and iiot, demand for…
E-Commerce Packaging Market is Growing Due to Growing Popularity of Smart Packag …
The growing popularity of smart packaging, increasing demand for protective packaging and secondary packaging are some of the major factors driving the growth of the E-commerce packaging market. However, the need for e-commerce packaging to comply with strict regulations, increasing environmental concerns for safety, complex supply chain, and difficulties in optimizing packaging size may restrain the growth of the e-commerce packaging market over the forecast period. The striking offers in…
Home Medical Equipment Market Is Growing with the Growing Geriatric Population
Home medical equipment refers to cost-effective medical devices that help provide safe and effective treatment to patients in the comfort of their home. It is a group of specialized devices used for patients whose medical care is being administered in a home or other personal setting; managed either by a caregiver or non-medical caregiver. The home medical equipment market growth is mainly driven by the increasing prevalence of chronic diseases…
DetailXPerts: A Growing Franchise System with Growing Territories
DetailXPerts is about to expand further its operations and territorial outreach, company executives revealed last week. More company-owned locations will be opening up throughout the US, covering new geographic areas and expanding on current ones. The growth in operations will ensure the company’s ability to answer the growing customer demand for top-notch professional detailing services. Additionally, it will fuel the growing franchise system as more and more qualified individuals are…
Retail Automation Market: Growing Adoption of Innovative and Efficient Technolog …
Retail automation solutions offer several advantages including accuracy, low cost, speed, and high performance primarily in the retail sector. This is a key factors fuelling growth of the retail automation market. Implementation of automated solutions in retail industry is the major factor propelling growth of the retail automation market. The retail automation systems are increasingly used in numerous end users including supermarkets, hypermarket, single item stores, and fuel station.
Browse The…
Global Biosimilar Market growing from USD 3.5 billion to growing CAGR of 27.0%
The Biosimilar Market report contains the necessitated information about market definition, classifications, applications and engagements for the Chemical and Materials industry market that are crucial to gain an upper hand in the market. Besides, the report also contains the company profiles of all the players mentioned above while explaining the drivers and restraints of the market with the help of SWOT analysis.
The global biosimilar market accounted to USD 3.5…